Compared to Estimates, Alignment Healthcare (ALHC) Q4 Earnings: A Look at Key Metrics

28.02.25 00:00 Uhr

Werte in diesem Artikel

Alignment Healthcare (ALHC) reported $701.24 million in revenue for the quarter ended December 2024, representing a year-over-year increase of 50.7%. EPS of -$0.16 for the same period compares to -$0.25 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $677.04 million, representing a surprise of +3.58%. The company delivered an EPS surprise of +11.11%, with the consensus EPS estimate being -$0.18.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Alignment Healthcare performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Medical Benefit Ratio: 87.5% versus the five-analyst average estimate of 89.4%. Health Plan Membership - Ending: 189,100 versus 185,005 estimated by four analysts on average. Revenues- Other: $9.46 million versus $7.48 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +48.3% change. Revenues- Earned premiums: $691.79 million versus $668.26 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +50.7% change. View all Key Company Metrics for Alignment Healthcare here>>>Shares of Alignment Healthcare have returned -14.1% over the past month versus the Zacks S&P 500 composite's -2.2% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Alignment Healthcare, Inc. (ALHC): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Alignment Healthcare

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Alignment Healthcare

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Alignment Healthcare Inc Registered Shs

Wer­bung